Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1989 Jan;65(1):45–56.

Immune modulation by aspirin during experimental rhinovirus colds.

J Hsia, G L Simon, N Higgins, A L Goldstein, F G Hayden
PMCID: PMC1807788  PMID: 2557948

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA. 1980 Feb 15;243(7):661–669. [PubMed] [Google Scholar]
  2. Denicoff K. D., Rubinow D. R., Papa M. Z., Simpson C., Seipp C. A., Lotze M. T., Chang A. E., Rosenstein D., Rosenberg S. A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 1987 Sep;107(3):293–300. doi: 10.7326/0003-4819-107-2-293. [DOI] [PubMed] [Google Scholar]
  3. Ernstoff M. S., Trautman T., Davis C. A., Reich S. D., Witman P., Balser J., Rudnick S., Kirkwood J. M. A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma. J Clin Oncol. 1987 Nov;5(11):1804–1810. doi: 10.1200/JCO.1987.5.11.1804. [DOI] [PubMed] [Google Scholar]
  4. Hayden F. G., Albrecht J. K., Kaiser D. L., Gwaltney J. M., Jr Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med. 1986 Jan 9;314(2):71–75. doi: 10.1056/NEJM198601093140202. [DOI] [PubMed] [Google Scholar]
  5. Hayden F. G., Gwaltney J. M., Jr Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha 2. Antiviral Res. 1983 Mar;3(1):67–71. doi: 10.1016/0166-3542(83)90016-5. [DOI] [PubMed] [Google Scholar]
  6. Hayden F. G., Gwaltney J. M., Jr Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. J Infect Dis. 1984 Aug;150(2):174–180. doi: 10.1093/infdis/150.2.174. [DOI] [PubMed] [Google Scholar]
  7. Hayden F. G., Gwaltney J. M., Jr Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. Antimicrob Agents Chemother. 1982 Jun;21(6):892–897. doi: 10.1128/aac.21.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. JACKSON G. G., DOWLING H. F., SPIESMAN I. G., BOAND A. V. Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med. 1958 Feb;101(2):267–278. doi: 10.1001/archinte.1958.00260140099015. [DOI] [PubMed] [Google Scholar]
  9. Klimt C. R., Knatterud G. L., Stamler J., Meier P. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol. 1986 Feb;7(2):251–269. doi: 10.1016/s0735-1097(86)80489-2. [DOI] [PubMed] [Google Scholar]
  10. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  11. Monto A. S., Shope T. C., Schwartz S. A., Albrecht J. K. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection. J Infect Dis. 1986 Jul;154(1):128–133. doi: 10.1093/infdis/154.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rosenberg S. A., Lotze M. T., Muul L. M., Chang A. E., Avis F. P., Leitman S., Linehan W. M., Robertson C. N., Lee R. E., Rubin J. T. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987 Apr 9;316(15):889–897. doi: 10.1056/NEJM198704093161501. [DOI] [PubMed] [Google Scholar]
  13. Roth M. S., Foon K. A. Alpha interferon in the treatment of hematologic malignancies. Am J Med. 1986 Nov;81(5):871–882. doi: 10.1016/0002-9343(86)90360-8. [DOI] [PubMed] [Google Scholar]
  14. Tyrrell D. A. The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit. J Antimicrob Chemother. 1986 Oct;18 (Suppl B):153–156. doi: 10.1093/jac/18.Supplement_B.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yousefi S., Chiu J., Carandang G., Archibeque E. G., Vaziri N., Cesario T. C. Effect of acetyl salicylic acid on production and action of leukocyte-derived interferons. Antimicrob Agents Chemother. 1987 Jan;31(1):114–116. doi: 10.1128/aac.31.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Zatz M. M., Skotnicki A., Bailey J. M., Oliver J. H., Goldstein A. L. Mechanism of action of thymosin. II. Effects of aspirin and thymosin on enhancement of IL-2 production. Immunopharmacology. 1985 Jun;9(3):189–198. doi: 10.1016/0162-3109(85)90015-3. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES